Prokarium secures £4.6m Wellcome funding for Entervax
- Posted on 9 October, 2019
Prokarium has announced an investment of £4.59 million from Wellcome to fund two clinical trials of its lead programme, Entervax.
Follow this link for further information
http://www.pharmatimes.com/news/prokarium_secures_4.6m_wellcome_funding_for_entervax_1312196
Share this article:
People also read
SynbiCITE Showcase 2022
The aim of the 1-Day SynbiTECH Showcase was to reflect important issues and changes in the field of synthetic biology/engineering biology. As with the...
Measurement for Recovery
Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...
SynbiTECH2020 is going virtual!
SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.